Dr. Lal Path Labs Ltd. allots 8.37 crore bonus shares in 1:1 ratio

Dr. Lal Path Labs Limited has announced the allotment of 8,37,75,510 fully paid-up bonus equity shares. These shares, each with a face value of ₹10, were allotted in a 1:1 ratio, meaning one new equi...

Dr. Lal Path Labs Limited has announced the allotment of 8,37,75,510 fully paid-up bonus equity shares. These shares, each with a face value of ₹10, were allotted in a 1:1 ratio, meaning one new equity share for every existing equity share held. The allotment was made to eligible members whose names appeared in the Register of Members or beneficial owners as of the record date, Friday, December 19, 2025. The Board of Directors approved this allotment through a circular resolution on Monday, December 22, 2025. Following this allotment, the company's paid-up equity share capital has increased to ₹1,67,55,10,200, comprising 16,75,51,020 fully paid-up equity shares of ₹10 face value each. The newly allotted bonus shares will rank pari passu with the existing equity shares in all respects.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Dr. Lal Path Labs Ltd. in the news today?

Dr. Lal Path Labs Ltd. (LALPATHLAB) is in the news due to the announcement is a factual update regarding the allotment of bonus shares, which is a standard corporate action and does not inherently indicate a positive or negative change in the company's financial performance or outlook.

Bonus IssueOther Regulatory Filings
Dr. Lal Path Labs Ltd.LALPATHLABhttps://prysm.fi/v2/analyze/LALPATHLAB

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Dr. Lal Path Labs Ltd. allots 8.37 crore bonus shares in 1:1 ratio

December 22, 2025, 03:50 AM

AI Sentiment Analysis

Dr. Lal Path Labs Limited has announced the allotment of 8,37,75,510 fully paid-up bonus equity shares.

These shares, each with a face value of ₹10, were allotted in a 1:1 ratio, meaning one new equity share for every existing equity share held. The allotment was made to eligible members whose names appeared in the Register of Members or beneficial owners as of the record date, Friday, December 19, 2025.

The Board of Directors approved this allotment through a circular resolution on Monday, December 22, 2025. Following this allotment, the company's paid-up equity share capital has increased to ₹1,67,55,10,200, comprising 16,75,51,020 fully paid-up equity shares of ₹10 face value each. The newly allotted bonus shares will rank pari passu with the existing equity shares in all respects.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained - “Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

Top Queries to Ask About Dr. Lal Path Labs Ltd.

More News on Dr. Lal Path Labs Ltd.

Discover more trending news on Prysm

View All